NASDAQ · Analyst Forecast

Erasca, Inc. (ERAS) Analyst Forecast

$14.99 NASDAQ: ERAS Market Cap $5.24B

Revenue and earnings estimates published by analysts covering Erasca, Inc. (ERAS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Erasca, Inc., analysts forecast revenue rising from $817.8B in 2025 to $353.94T in 2030; the average estimate for 2030 earnings per share is $-0.43; 8 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

Measure	Value
Current priceWhat the share trades at now.	$14.99
Consensus targetThe average of the price targets analysts have published.	$22.50
Median targetThe middle target, less affected by a single outlier.	$21.50
Highest targetThe most optimistic published target.	$30.00
Lowest targetThe most pessimistic published target.	$16.00
Difference from priceHow far the consensus target sits from today’s price.	+50.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2025	$817.8B	$817.8B	$817.8B	8
2026	$7.52T	$7.52T	$7.52T	7
2027	$375.0B	$375.0B	$375.0B	7
2028	$2.75T	$2.75T	$2.75T	7
2029	$41.49T	$41.49T	$41.49T	4
2030	$353.94T	$353.94T	$353.94T	4

Earnings per share forecast

Year	Low	Average	High	Analysts
2025	$-0.45	$-0.44	$-0.43	8
2026	$-1.04	$-0.97	$-0.94	7
2027	$-0.74	$-0.62	$-0.55	7
2028	$-1.02	$-0.78	$-0.60	7
2029	$-0.94	$-0.94	$-0.94	4
2030	$-0.43	$-0.43	$-0.43	4

Erasca, Inc. (ERAS) forecast — frequently asked questions

What is the analyst price target for Erasca, Inc.?

Analysts covering Erasca, Inc. (ERAS) have a consensus price target of $22.50, 50.1% above the current price of $14.99. Published targets range from $16.00 to $30.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Erasca, Inc.'s earnings?

The average analyst estimate for Erasca, Inc. (ERAS) earnings per share in 2030 is -0.43, with individual estimates between -0.43 and -0.43.

How much revenue is Erasca, Inc. expected to make?

Analysts forecast Erasca, Inc. (ERAS) revenue of $353.94T in 2030, based on 4 published estimates.

How many analysts cover ERAS?

8 analysts contribute estimates for Erasca, Inc. (ERAS). Thin coverage makes an average less reliable.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.